SWS Hemodialysis Care Co., Ltd. (SHA:688410)

SWS Hemodialysis Care Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	185.22	145.89	70.89	194.5	59.24	19.47
Depreciation & Amortization	20.26	21.38	21.56	18.65	16.8	17.11
Other Amortization	2.23	1.76	0.86	1.18	1.83	2.31
Loss (Gain) From Sale of Assets	-0.02	-0.03	-0.35	-0.61	-0.05	-0.04
Asset Writedown & Restructuring Costs	13.27	13.04	8.64	0.16	0.38	0.41
Loss (Gain) From Sale of Investments	-20.04	-18.67	-22.21	-17.46	-1.87	-3.91
Provision & Write-off of Bad Debts	-0.51	2.68	-1.73	3.4	3.03	1.67
Other Operating Activities	9.06	9.74	3.9	6.73	1.05	1.08
Change in Accounts Receivable	-23.29	-19.6	-1.34	17.91	-12.03	-37.01
Change in Inventory	-54.83	-41.4	-14.86	-23.42	-74.95	13.78
Change in Accounts Payable	161.8	204.04	67.94	-149.12	252.31	17.65
Change in Other Net Operating Assets	-18.44	-11.62	11.94	16.8	1.57	2.24
Operating Cash Flow	280.57	308.01	143.15	64.55	245.85	32.76
Operating Cash Flow Growth	52.35%	115.17%	121.75%	-73.74%	650.41%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-260.05	-156.14	-83.18	-112.52	-12.95	-28.08
Sale of Property, Plant & Equipment	0.9	0.93	0.02	0.15	0.18	0.75
Divestitures	-	-	1.5	2.6	-	-
Investment in Securities	272	-124.4	-109.1	-501.86	0.3	3.2
Other Investing Activities	20.42	18.02	21.29	13.08	5.32	2.63
Investing Cash Flow	33.26	-261.6	-169.47	-598.56	-7.15	-21.49

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Repaid	-	-2.46	-3.8	-16.2	-10.72	-78
Lease Payments	-2.29	-2.46	-3.8	-3.4	-2.72	-
Net Debt Issued (Repaid)	-2.29	-2.46	-3.8	-16.2	-10.72	-78
Issuance of Common Stock	13.56	-	14.12	-	1,089	-
Repurchase of Common Stock	-0.01	-0.01	-50.33	-	-	-
Common Dividends Paid	-	-31.96	-43.13	-29.13	-0.74	-1.78
Dividends Paid	-	-31.96	-43.13	-29.13	-0.74	-1.78
Other Financing Activities	-14.11	-14.11	-	-3.64	-20.15	0.65
Financing Cash Flow	-2.84	-48.55	-83.14	-48.96	1,058	-79.13

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-1.34	-1.28	0.01	-0.05	-0.03	0.02
Net Cash Flow	309.64	-3.42	-109.45	-583.01	1,296	-67.84

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	20.51	151.87	59.97	-47.97	232.9	4.69
Free Cash Flow Growth	-54.68%	153.24%	-	-	4870.12%	-
Free Cash Flow Margin	2.25%	18.82%	10.57%	-6.95%	60.97%	1.65%
Free Cash Flow Per Share	0.05	0.34	0.13	-0.11	0.52	0.01
Levered Free Cash Flow	96.72	158.72	57.93	-140.48	209	-24.45
Unlevered Free Cash Flow	96.84	158.89	58.11	-140.38	209.5	-23.44
Free Cash Flow After Leases	18.22	149.41	56.17	-51.37	230.18	4.69

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	39.31	21.66	20.07	-	12.65	14.52
Change in Working Capital	71.11	132.23	61.59	-142	165.43	-5.34

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 28, 2026

Data Sources Report a data error